Medicine for treating irritable bowel syndrome

Abstract

The invention relates to a medicine for treating irritable bowel syndrome. The medicine is prepared from the following medicinal raw materials: 16 parts of ceriops tagal, 12 parts of levisticum officinale, 13 parts of resina populi, 12 parts of nauclea, 15 parts of decaisnea roots, 10 parts of bottlebrush orchid, 10 parts of cowherb seeds, 11 parts of medicinal cyathula roots, 10 parts of cortex acanthopanacis, 10 parts of himalayan reasel roots, 11 parts of red dates, 11 parts of vicia hirsute, 8 parts of fructus piperis longi, 9 parts of Chinese wolfberries, 8 parts of flatstem milkvetch seeds, 8 parts of pilea peploides (Gaud.)Hook.et Arn.var.major Wedd., 7 parts of tall gastrodia tubers, 8 parts of roots of common triplostegia, 9 parts of siberian cocklour fruits, 8 parts of biond magnolia flowers, 7 parts of fineleaf schizonepeta herbs, 8 parts of corn stigmas, 3 parts of rehmannia roots, 2 parts of turmeric root-tubers, 1 part of black sesame, 5 parts of safflowers, 2 parts of green beans, 3 parts of eucommia barks, 2 parts of topinamber, 3 parts of sharpleaf galangal fruits, 1 part of south dodder seeds, 2 parts of bergia ammannioides roxb. ex roth, 3 parts of thinleaf milkwort root-barks and 2 parts of calmus. The medicine for treating irritable bowel syndrome is reasonable in formula, and has the characteristics of definite curative effect, safety, convenience and low cost; moreover, the toxic or side effects are avoided.

Description

[0001] The present invention is a divisional application of a patent with an application date of March 17, 2014, an application number of 2014100977670, and an invention title of "a drug for treating irritable bowel syndrome and its application". technical field [0002] The invention relates to the field of medicine, in particular to a medicine for treating irritable bowel syndrome. Background technique [0003] Irritable bowel syndrome (IBS) is a group of unexplained bowel dysfunction syndromes characterized by abdominal discomfort or abdominal pain, changes in bowel habits, and abnormal stool properties, without any organic or abnormal biochemical indicators clinically. The disease was once called "allergic colitis", "irritable colitis" or "fluid-sparing colitis". The etiology and pathogenesis of this disease are not clear so far, so the demand for drugs with special curative effects is increasing. [0004] Traditional Chinese medicine is often produced by decocting decoc...

AI Technical Summary

Problems solved by technology

[0004] Traditional Chinese medicine is often produced by decocting decoctions, oral tablets, capsules, etc., but its active ingredients may be greatly reduced after passing through the human gastrointestinal tract.